$SCYX
SCYNEXIS Inc Stock $scyx

$scyx Overview Financials Valuation SEC Filings Company Website

2016 Q2 Form 10-Q Financial Statement

#000162828016018653 Filed on August 08, 2016

Income Statement

Concept	2016 Q2	2015 Q2
Revenue	$64.00K	$64.00K
YoY Change	0.0%	-1.54%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.673M	$3.275M
YoY Change	-48.92%	45.23%
% of Gross Profit
Research & Development	$6.659M	$3.282M
YoY Change	102.89%	80.03%
% of Gross Profit
Depreciation & Amortization	$10.00K	$124.0K
YoY Change	-91.94%	-59.61%
% of Gross Profit
Operating Expenses	$8.332M	$6.557M
YoY Change	27.07%	60.79%
Operating Profit	-$8.268M	-$6.493M
YoY Change	27.34%	61.8%
Interest Expense	$0.00	$1.000K
YoY Change	-100.0%	-120.0%
% of Operating Profit
Other Income/Expense, Net	$140.0K	$1.000K
YoY Change	13900.0%	-99.98%
Pretax Income	-$8.130M	-$6.490M
YoY Change	25.27%	-488.62%
Income Tax
% Of Pretax Income
Net Earnings	-$8.128M	-$9.497M
YoY Change	-14.42%	-525.3%
Net Earnings / Revenue	-12700.0%	-14839.06%
Basic Earnings Per Share	-$0.56	-$0.78
Diluted Earnings Per Share	-$5.568M	-$0.78
COMMON SHARES
Basic Shares Outstanding	23.42M shares	12.25M shares
Diluted Shares Outstanding		12.25M shares

Balance Sheet

Concept	2016 Q2	2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$50.30M	$57.10M
YoY Change	-11.91%	48.7%
Cash & Equivalents	$37.87M	$57.06M
Short-Term Investments	$12.50M
Other Short-Term Assets	$60.00K	$777.0K
YoY Change	-92.28%	-44.5%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$52.74M	$64.65M
YoY Change	-18.42%	58.44%
LONG-TERM ASSETS
Property, Plant & Equipment		$0.00
YoY Change		-100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$426.0K	$33.00K
YoY Change	1190.91%	-69.44%
Total Long-Term Assets	$786.0K	$33.00K
YoY Change	2281.82%	-99.36%
TOTAL ASSETS
Total Short-Term Assets	$52.74M	$64.65M
Total Long-Term Assets	$786.0K	$33.00K
Total Assets	$53.52M	$64.68M
YoY Change	-17.25%	40.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.136M	$477.0K
YoY Change	138.16%	-26.16%
Accrued Expenses	$2.910M	$2.835M
YoY Change	2.65%	12.77%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.523M	$7.051M
YoY Change	-35.85%	86.49%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$5.100M	$900.0K
YoY Change	466.67%	-67.86%
Total Long-Term Liabilities	$5.100M	$900.0K
YoY Change	466.67%	-67.86%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.523M	$7.051M
Total Long-Term Liabilities	$5.100M	$900.0K
Total Liabilities	$9.649M	$7.906M
YoY Change	22.05%	20.96%
SHAREHOLDERS EQUITY
Retained Earnings	-$165.4M	-$133.4M
YoY Change	24.03%	20.57%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$43.88M	$56.77M
YoY Change
Total Liabilities & Shareholders Equity	$53.52M	$64.68M
YoY Change	-17.25%	40.73%

Cashflow Statement

Concept	2016 Q2	2015 Q2
OPERATING ACTIVITIES
Net Income	-$8.128M	-$9.497M
YoY Change	-14.42%	-525.3%
Depreciation, Depletion And Amortization	$10.00K	$124.0K
YoY Change	-91.94%	-59.61%
Cash From Operating Activities	-$8.990M	-$8.270M
YoY Change	8.71%	95.51%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$360.0K
YoY Change	-100.0%	44.0%
Acquisitions
YoY Change
Other Investing Activities	-$12.47M	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$12.48M	-$360.0K
YoY Change	3366.67%	800.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	21.31M	38.06M
YoY Change	-44.01%	-9.47%
NET CHANGE
Cash From Operating Activities	-8.990M	-8.270M
Cash From Investing Activities	-12.48M	-360.0K
Cash From Financing Activities	21.31M	38.06M
Net Change In Cash	-160.0K	29.43M
YoY Change	-100.54%	-22.08%
FREE CASH FLOW
Cash From Operating Activities	-$8.990M	-$8.270M
Capital Expenditures	$0.00	-$360.0K
Free Cash Flow	-$8.990M	-$7.910M
YoY Change	13.65%	98.74%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Period End Date DocumentPeriodEndDate	2016-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001178253
CY2016Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23424741	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	1999-11-04
	dei	Entity Registrant Name EntityRegistrantName	SCYNEXIS INC
CY2015Q4	scyx	Accrued Researchand Development Expense Current AccruedResearchandDevelopmentExpenseCurrent	1903000	USD
CY2016Q2	scyx	Accrued Researchand Development Expense Current AccruedResearchandDevelopmentExpenseCurrent	2193000	USD
CY2015Q4	scyx	Accrued Severanceand Retention Costs Current AccruedSeveranceandRetentionCostsCurrent	2639000	USD
CY2016Q2	scyx	Accrued Severanceand Retention Costs Current AccruedSeveranceandRetentionCostsCurrent	220000	USD
CY2016Q2	scyx	Additional Milestone Payments Maximum AdditionalMilestonePaymentsMaximum	2300000	USD
	scyx	Deferred Offering Costs Incurred But Not Yet Paid DeferredOfferingCostsIncurredButNotYetPaid	53000	USD
	scyx	Deferred Offering Costs Incurred But Not Yet Paid DeferredOfferingCostsIncurredButNotYetPaid	205000	USD
	scyx	Deferred Offering Costs Reclassified To Additional Paid In Capital DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital	3388000	USD
	scyx	Deferred Offering Costs Reclassified To Additional Paid In Capital DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital	65000	USD
CY2013Q3	scyx	Deferred Revenue Recognition Period DeferredRevenueRecognitionPeriod	P70M
CY2015Q4	scyx	Disposal Group Including Discontinued Operations Cash Held In Escrow DisposalGroupIncludingDiscontinuedOperationsCashHeldInEscrow	500000	USD
CY2016Q2	scyx	Disposal Group Including Discontinued Operations Cash Held In Escrow DisposalGroupIncludingDiscontinuedOperationsCashHeldInEscrow	500000	USD
	scyx	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-122000	USD
	scyx	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	0	USD
CY2016Q2	scyx	Number Of License Agreements NumberOfLicenseAgreements	2	Agreement
CY2015Q4	scyx	Prepaid Researchand Development Expenses Current PrepaidResearchandDevelopmentExpensesCurrent	108000	USD
CY2016Q2	scyx	Prepaid Researchand Development Expenses Current PrepaidResearchandDevelopmentExpensesCurrent	422000	USD
	scyx	Property And Equipment Purchases In Accounts Payable PropertyAndEquipmentPurchasesInAccountsPayable	20000	USD
	scyx	Property And Equipment Purchases In Accounts Payable PropertyAndEquipmentPurchasesInAccountsPayable	0	USD
CY2015Q2	scyx	Researchand Development Expense Gross ResearchandDevelopmentExpenseGross	3820000	USD
	scyx	Researchand Development Expense Gross ResearchandDevelopmentExpenseGross	7801000	USD
CY2016Q2	scyx	Researchand Development Expense Gross ResearchandDevelopmentExpenseGross	6827000	USD
	scyx	Researchand Development Expense Gross ResearchandDevelopmentExpenseGross	11789000	USD
CY2015Q2	scyx	Researchand Development Income Reimbursement ResearchandDevelopmentIncomeReimbursement	538000	USD
	scyx	Researchand Development Income Reimbursement ResearchandDevelopmentIncomeReimbursement	732000	USD
CY2016Q2	scyx	Researchand Development Income Reimbursement ResearchandDevelopmentIncomeReimbursement	168000	USD
	scyx	Researchand Development Income Reimbursement ResearchandDevelopmentIncomeReimbursement	387000	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	619000	USD
CY2016Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1136000	USD
CY2015Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	776000	USD
CY2016Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	413000	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3149000	USD
CY2016Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2910000	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	192069000	USD
CY2016Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	209298000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	616000	USD
CY2015Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	819000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1115000	USD
CY2016Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	342000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	616000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	111000	USD
CY2015Q4	us-gaap	Assets Assets	49273000	USD
CY2016Q2	us-gaap	Assets Assets	53524000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	48437000	USD
CY2016Q2	us-gaap	Assets Current AssetsCurrent	52738000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32243000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	57057000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46985000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	37865000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	24814000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-9120000	USD
CY2015Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	14033	shares
CY2016Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	14033	shares
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	2161458	shares
CY2016Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	6964613	shares
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13905599	shares
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23424741	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13905599	shares
CY2016Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23424741	shares
CY2015Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	14000	USD
CY2016Q2	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	23000	USD
CY2015Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	417000	USD
CY2016Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts	360000	USD
CY2015Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	25000	USD
CY2016Q2	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	25000	USD
CY2015Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	257000	USD
CY2016Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	257000	USD
CY2015Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	635000	USD
CY2016Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	507000	USD
	us-gaap	Depreciation Depreciation	447000	USD
	us-gaap	Depreciation Depreciation	7000	USD
CY2015Q2	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.25
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.33
CY2016Q2	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	0.00
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	0.00
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.78
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.53
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.07
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	42000	USD
CY2016Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	25000	USD
CY2015Q2	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2016Q2	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2015Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2016Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-101000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-101000	USD
CY2016Q2	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	12472000	USD
CY2016Q2	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	3000	USD
CY2016Q2	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	8000	USD
CY2015Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	0	USD
CY2016Q2	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	12472000	USD
CY2016Q2	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	12467000	USD
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	1350000	USD
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-6492000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-12423000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-8128000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-15312000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.53
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.20
CY2016Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.56
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.07
CY2015Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-3005000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-3458000	USD
CY2016Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	467000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	278000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	214000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-218000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-128000	USD
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	1262000	USD
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	1003000	USD
	us-gaap	Increase Decrease In Restructuring Reserve IncreaseDecreaseInRestructuringReserve	1499000	USD
	us-gaap	Increase Decrease In Restructuring Reserve IncreaseDecreaseInRestructuringReserve	-2419000	USD
CY2015Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	2000	USD
CY2016Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	39000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	67000	USD
	us-gaap	Interest Paid InterestPaid	0	USD
	us-gaap	Interest Paid InterestPaid	67000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	7324000	USD
CY2016Q2	us-gaap	Liabilities Liabilities	9649000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	49273000	USD
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	53524000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6664000	USD
CY2016Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4523000	USD
CY2016Q2	us-gaap	License And Services Revenue LicenseAndServicesRevenue	64000	USD
	us-gaap	License And Services Revenue LicenseAndServicesRevenue	129000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	38160000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	21317000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-527000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12486000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12819000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-17951000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-9497000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-15881000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-8128000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-15312000	USD
CY2015Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2000	USD
CY2016Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	140000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	168000	USD
CY2015Q4	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	430000	USD
CY2016Q2	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	816000	USD
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	6557000	USD
	us-gaap	Operating Expenses OperatingExpenses	12554000	USD
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	8332000	USD
	us-gaap	Operating Expenses OperatingExpenses	15609000	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-6493000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12425000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-8268000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-15480000	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	640000	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	0	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	0	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	182000	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	307000	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2016Q2	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	151000	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	428000	USD
CY2016Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	279000	USD
CY2015Q4	us-gaap	Other Assets Current OtherAssetsCurrent	38000	USD
CY2016Q2	us-gaap	Other Assets Current OtherAssetsCurrent	60000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	419000	USD
CY2016Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	426000	USD
CY2015Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	91000	USD
CY2016Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	153000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	3335000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1746000	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	12472000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	527000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2016Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2016Q2	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1452000	USD
CY2016Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2401000	USD
CY2015Q4	us-gaap	Prepaid Insurance PrepaidInsurance	285000	USD
CY2016Q2	us-gaap	Prepaid Insurance PrepaidInsurance	450000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	41400000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	22500000	USD
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	USD
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	558000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	95000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	5000	USD
CY2013Q3	us-gaap	Proceeds From License Fees Received ProceedsFromLicenseFeesReceived	1500000	USD
	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	0	USD
CY2015Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2016Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Profit Loss ProfitLoss	-15881000	USD
	us-gaap	Profit Loss ProfitLoss	-15312000	USD
CY2015Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3282000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7069000	USD
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6659000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11402000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-150134000	USD
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-165446000	USD
CY2015Q2	us-gaap	Revenues Revenues	64000	USD
	us-gaap	Revenues Revenues	129000	USD
CY2016Q2	us-gaap	Revenues Revenues	64000	USD
	us-gaap	Revenues Revenues	129000	USD
CY2015Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3275000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5485000	USD
CY2016Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1673000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4207000	USD
CY2015Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	1379727	shares
CY2016Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	1804473	shares
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	5000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	41949000	USD
CY2016Q2	us-gaap	Stockholders Equity StockholdersEquity	43875000	USD
CY2015Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	USD
CY2016Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	4594000	USD
CY2015Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	12249487	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	10393289	shares
CY2016Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	14590733	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	14248166	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;padding-left:0px;text-indent:30px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-style:italic;font-weight:normal;text-decoration:none;">Concentration of Credit Risk</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">Financial instruments, which potentially expose the Company to concentrations of credit risk, consist principally of cash on deposit with a bank, which exceeds the FDIC insurance limits, as well as accounts receivable. Ongoing credit evaluations of the bank and customers' financial condition and independent ratings are reviewed by the Company. Collateralization of deposits has not been required. </font></div></div>
	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;padding-left:0px;text-indent:30px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-style:italic;font-weight:normal;text-decoration:none;">Revenue Recognition and Deferred Revenue</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">The Company has entered into collaboration arrangements in exchange for non-refundable upfront payments and consideration as services are performed. These arrangements include multiple elements, such as the sale of licenses and the provision of services. Under these arrangements, the Company also is entitled to receive development milestone payments and royalties in the form of a designated percentage of product sales. The Company classifies non-refundable upfront payments, milestone payments and royalties received under collaboration and licensing agreements as revenues within its statements of operations because the Company views such activities as being central to its business operations.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">Revenue is recognized when all of the following conditions are met: (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred or services have been rendered, (iii) fees are fixed or determinable, and (iv) collection of fees is reasonably assured. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">When entering into an arrangement, the Company first determines whether the arrangement includes multiple deliverables and is subject to accounting guidance in ASC subtopic 605-25, </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:italic;">Multiple-Element Arrangements</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">. If the Company determines that an arrangement includes multiple elements, it determines whether the arrangement should be divided into separate units of accounting and how the arrangement consideration should be measured and allocated among the separate units of accounting. An element qualifies as a separate unit of accounting when the delivered element has standalone value to the customer. The Company’s arrangements do not include a general right of return relative to delivered elements. Any delivered elements that do not qualify as separate units of accounting are combined with other undelivered elements within the arrangement as a single unit of accounting. If the arrangement constitutes a single combined unit of accounting, the Company determines the revenue recognition method for the combined unit of accounting and recognizes the revenue over the period from inception through the date the last deliverable within the single unit of accounting is delivered.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">Non-refundable upfront license fees are recorded as deferred revenue and recognized into revenue on a straight-line basis over the estimated period of the Company’s substantive performance obligations. If the Company does not have substantive performance obligations, the Company recognizes non-refundable upfront fees into revenue through the date the deliverable is satisfied. Analyzing the arrangement to identify deliverables requires the use of judgment and each deliverable may be an obligation to deliver services, a right or license to use an asset, or another performance obligation. In arrangements that include license rights and other non-contingent deliverables, such as participation in a steering committee, these deliverables do not have standalone value because the non-contingent deliverables are dependent on the license rights. That is, the non-contingent deliverables would not have value without the license rights, and only the Company can perform the related services. Upfront license rights and non-contingent deliverables, such as participation in a steering committee, do not have standalone value as they are not sold separately and they cannot be resold. In addition, when non-contingent deliverables are sold with upfront license rights, the license rights do not represent the culmination of a separate earnings process. As such, the Company accounts for the license and the non-contingent deliverables as a single combined unit of accounting. In such instances, the license revenue in the form of non-refundable upfront payments is deferred and recognized over the applicable relationship period, which historically has been the estimated period of the Company’s substantive performance obligations or the period the rights granted are in effect. The Company recognizes contingent event-based payments under license agreements when the payments are received. The Company has not received any royalty payments to date.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">The Company will recognize a milestone payment when earned if it is substantive and the Company has </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">no</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> ongoing performance obligations related to the milestone. A milestone payment is considered substantive if it: 1) is commensurate with either the Company’s performance to achieve the milestone or the enhanced value of the delivered item as a result of a specific outcome from the Company’s performance to achieve the milestone; 2) relates solely to past performance; and 3) is reasonable relative to all of the deliverables and payment terms, including other potential milestone consideration, within the arrangement.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">Amounts received prior to satisfying all revenue recognition criteria are recorded as deferred revenue in the accompanying balance sheets.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">The Company’s deferred revenue includes non-refundable upfront payments received under certain licensing and collaboration arrangements that contain substantive performance obligations that the Company is providing over respective defined service or estimated relationship periods. Such non-refundable upfront payments are recognized over these defined service or estimated relationship periods.</font></div></div>

Files In Submission

Name	View Source	Status
0001628280-16-018653-index-headers.html	Edgar Link	pending
0001628280-16-018653-index.html	Edgar Link	pending
0001628280-16-018653.txt	Edgar Link	pending
0001628280-16-018653-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
q22016exhibit121.htm	Edgar Link	pending
q22016exhibit311.htm	Edgar Link	pending
q22016exhibit312.htm	Edgar Link	pending
q22016exhibit321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
scyx-20160630.xml	Edgar Link	completed
scyx-20160630.xsd	Edgar Link	pending
scyx-20160630x10q.htm	Edgar Link	pending
scyx-20160630_cal.xml	Edgar Link	unprocessable
scyx-20160630_def.xml	Edgar Link	unprocessable
scyx-20160630_lab.xml	Edgar Link	unprocessable
scyx-20160630_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SCYX
SCYNEXIS Inc Stock $scyx

2016 Q2 Form 10-Q Financial Statement

#000162828016018653 Filed on August 08, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCYX SCYNEXIS Inc Stock $scyx

2016 Q2 Form 10-Q Financial Statement

#000162828016018653 Filed on August 08, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCYX
SCYNEXIS Inc Stock $scyx